Maura L Gillison
Overview
Explore the profile of Maura L Gillison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
20584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wotman M, Xiao W, Du R, Jiang B, Akagi K, Liu S, et al.
Head Neck Pathol
. 2025 Feb;
19(1):25.
PMID: 39998590
Purpose: Plasma circulating tumor HPV DNA (ctHPVDNA) persistence after curative-intent treatment may identify patients with HPV-positive cancers at risk for recurrence. Technical validation is required for use as an integral...
2.
Colevas A, Cmelak A, Pfister D, Spencer S, Adkins D, Birkeland A, et al.
J Natl Compr Canc Netw
. 2025 Feb;
23(2):2-11.
PMID: 39938471
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary...
3.
Landy R, Haber G, Graubard B, Fakhry C, Campos N, Burger E, et al.
J Natl Cancer Inst
. 2025 Feb;
PMID: 39913364
Background: We estimated the impact of screening on morbidity and mortality of HPV16-positive oropharyngeal cancer among US men aged 45-79 years. Methods: We developed an individual-level, state-transition natural history microsimulation...
4.
Morris V, Xiao W, Lin K, Wong C, Wotman M, Holliday E, et al.
Clin Cancer Res
. 2025 Jan;
PMID: 39873618
Background: While detection of circulating tumor DNA (ctDNA) weeks after surgery is linked to recurrence for other solid tumors, the optimal time point for ctDNA assessment as a prognostic biomarker...
5.
Moreno Rueda L, Wang H, Akagi K, Dang M, Vora A, Qin L, et al.
Cell Rep Med
. 2025 Jan;
6(2):101925.
PMID: 39855192
Multiple myeloma is a clonal plasma cell (PC) dyscrasia that arises from precursors and has been studied utilizing approaches focused on CD138 cells. By combining single-cell RNA sequencing (scRNA-seq) with...
6.
Colevas A, Talebi Z, Winters E, Even C, Lee V, Gillison M, et al.
Clin Cancer Res
. 2025 Jan;
31(5):815-823.
PMID: 39831818
Purpose: A first-in-human phase I study was conducted in patients with nasopharyngeal carcinoma to assess the safety and tolerability of VK-2019, a small-molecule selective inhibitor of Epstein-Barr virus (EBV) nuclear...
7.
Seo A, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, et al.
Clin Cancer Res
. 2024 Dec;
31(4):697-706.
PMID: 39680029
Purpose: Human papillomavirus (HPV) is a significant cause of cervical cancer. We hypothesized that detecting viral cell-free HPV DNA (cfDNA) before, during, and after chemoradiation (chemoRT) could provide insights into...
8.
Chaturvedi A, Vogtmann E, Shi J, Yano Y, Blaser M, Bokulich N, et al.
medRxiv
. 2024 Dec;
PMID: 39677463
Importance: The oral microbiome is increasingly recognized to play key roles in human health and disease; yet, population-representative characterizations are lacking. Objective: Characterize the composition, diversity, and correlates of the...
9.
Vogtmann E, Yano Y, Shi J, Wan Y, Purandare V, McLean J, et al.
medRxiv
. 2024 Dec;
PMID: 39677439
Importance: Poor oral health, including periodontal disease, is associated with oral microbiome changes and increased mortality risk. However, no large studies have evaluated whether the oral microbiome is directly associated...
10.
Johnson F, OHara M, Yapindi L, Jiang P, Tran H, Reuben A, et al.
Clin Cancer Res
. 2024 Nov;
31(3):479-490.
PMID: 39589337
Purpose: Effective therapy for recurrent head and neck squamous cell carcinoma (HNSCC) that is refractory to chemotherapy and immunotherapy is a considerable need. Aurora kinase A inhibition leads to apoptosis...